Pharmacokinetic analysis of flomoxef in children undergoing cardiopulmonary bypass and modified ultrafiltration

General Thoracic and Cardiovascular Surgery

Volumn 56, Issue 4, 2008, Pages 163-169

  Masuda, Zenichi ^a   Kurosaki, Yuji ^b   Ishino, Kozo ^a   Yamauchi, Keita ^b   Sano, Shunji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Cardiopulmonary bypass; Children; Flomoxef; Pharmacokinetics; Ultrafiltration

Indexed keywords

FLOMOXEF;

ANESTHESIA INDUCTION; ARTICLE; BLOOD SAMPLING; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; COMPARTMENT MODEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EXCRETION; FEMALE; HEART SURGERY; HUMAN; INFANT; MALE; MODIFIED ULTRAFILTRATION; PARAMETER; PRESCHOOL CHILD; SCHOOL CHILD; URINALYSIS;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; FEMALE; HEMOFILTRATION; HUMANS; INFANT; MALE;

EID: 41949116176     PISSN: 18636705     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11748-007-0208-5     Document Type: Article

References (17)

1. Holley FO, Pnganis KV, Stanski DR. Effect of cardiopulmonary bypass on the pharmacokinetics of drugs. Clin Pharmacokinet 1982;7:234-251.
2. Buylaert WA, Herregods LL, Mortier EP, Bogaert MG. Cardiopulmonary bypass and pharmacokinetics of drugs. Clin Pharmacokinet 1989;17:10-26.
3. Elliott MJ. Ultrafiltration and modified ultrafiltration in pediatric open heart operations. Ann Thorac Surg 1993;56:1518-1522.
4. Hatzopoulos FK, Stile-Calligaro IL, Rodvold KA, Sullivan-Bolyai J, Del Nido P, Levitsky S. Pharmacokinetics of intravenous vancomycin in pediatric cardiopulmonary bypass surgery. Pediatr Infect Dis J 1993;12:300-304.
5. Amaker RD, DiPiro JT, Bhatia J. Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation. Antimicrob Agents Chemother 1996;40:1139-1142.
6. Shimizu K. Flomoxef. Jpn J Antibiot 1988;12:1809-1821 (in Japanese).
7. Ohkubo A, Okamoto Y. Biological microassay of antibiotic concentrations in body fluids and tissue homogenates with band-culture method. Nippon Rinsho 1973;31:441-447 (in Japanese).
8. Yamaoka K, Tanigawara Y, Uno T. A pharmacokinetic analysis program (MULTI) for microcomputer. J Pharmacobiodyn 1981;4:879-885.
9. Nishino T, Otsuki M, Higashiyama I, Yamashita Y, Tanino T. Bacteriological evaluation of 6315-S (flomoxef), a new oxacephem antibiotic. Chemotherapy 1987;35:57-75 (in Japanese).
10. Joumois D, Israel-Biet D, Pouard P, Rolland B, Silvester W, Vouhe P, et al. High-volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology 1996;85:965-976.
11. O'Rullian JJ, Wise RK, McCoach RM, Kingsley CP. The effets of haemofi ltration on cefazolin levels during cardiopulmonary bypass. Perfusion 1998;13:176-180.
12. Kreter B, Woods M. Antibiotic prophylaxis for cardiothoracic operations: meta-analysis of thirty years of clinical trials. J Thorac Cardiovasc Surg 1992;104:590-599.
13. Townsend TR, Reitz BA, Bilker WB, Barlett JG. Clinical trial of cefamandole, cefazolin, and cefuroxime for antibiotic prophylaxis in cardiac operations. J Thorac Cardiovasc Surg 1993;106:664-700.
14. Mouton JW, Vinks AATMM. Is continuous infusion of betalactam antibiotics worthwhile? Efficacy and pharmacokinetic considerations. J Antimicrob Chemother 1996;38:5-15.
15. Menges T, Sablotzki A, Welters I, Wagner RM, Zickman B, Grounau S. Concentration of cefamandole in plasma and tissues of patients undergoing cardiac surgery: the influence of different cefamandole dosage. J Cardiothorac Casc Anesth 1997;11:565-570.
16. Porter GA, Kloster FE, Herr RJ, Starr A, Griswold HE, Kimsey J, et al. Relationship between alterations in renal hemodynamics during cardiopulmonary bypass and postoperative renal function. Circulation 1966;34:1005-1021.
17. Desmond PV, Roberts RK, Wood AJJ, Dunn GD, Wilkinson GR, Schenkerz S. Effect of heparin administration on plasma binding benzodiazepines. Br J Clin Pharmacol 1980;9:171-175.